| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc8b706fb22ca0baba35f66ce3e501ef |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate |
2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3f349d0a3848b9bf7fb08dc7d8c8cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f617e591547918ddef930563b9be8590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673b1ea8461f3b4aa42e226f5ee2170e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_453493553572cb85b4db9f495cd7057a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f29b2f6512ad5a9385b6e06bf5a842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9271164b22838f40a728fc4c3ccc81cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_289de5038a9fb68b52150f58a1476cae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c27bbe3e69737ff6af83bafc6f7151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c191338672671892d66a5cee6d59f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7ee5fcb77f9aaac209e0b29f3e673de |
| publicationDate |
2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3257856-A1 |
| titleOfInvention |
Crystal form a of compound and preparation method thereof |
| abstract |
The present invention relates to crystal form A of a compound. The present invention also discloses a preparation method and a pharmaceutical composition of the crystal form A. The crystal form A has strong hypoglycemic activity in vivo and is expected to be a novel pharmaceutically active ingredient for treating or preventing type II diabetes and/or complications of type II diabetes. |
| priorityDate |
2015-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |